66th ASH Annual Meeting: ASH Poster Walk on Health Equity in Hematology

ASH Poster Walks

Clinical Practice (Health Services and Quality), Workforce, Education, Diversity, Equity, and Inclusion (DEI)

(Virtual Program)

This Poster Walk will highlight works that investigate structural barriers impacting provision of care across hematology for patients from underserved racial/ ethnic groups, those of lower socio-economic status, and other vulnerable groups. In particular, the walk will spotlight research (featured in the posters) that advances efforts to diversify patient populations, mitigate barriers to care, and maximize the equitable provision of optimal care for patients from vulnerable populations. The walk will also feature posters outlining work being done to make our field more inclusive for patients, donors, and caregivers, as well as for practitioners across the hematology workforce. It will serve to connect stakeholders in health equity in hematology and facilitate discussions on the state of health equity research in the field.

Join us for this virtual Poster Walk session.

3701

"There Is so Much Power in Just Believing Someone": Understanding the Lived Experiences of Women with Heavy Vaginal Blood Loss

Fartoon M Siad, MD, MSc¹, Andrea Lausman, MD²^*, Carolyn Snider, MD³^*, Martina Trinkaus, MD⁴^*, Filomena Meffe, MD, MSc²^* and Michelle Sholzberg, MD, M.Sc⁵

¹Department of Medicine, University of Toronto, Toronto, ON, Canada
²Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada
³Department of Emergency Medicine, University of Toronto, Toronto, Canada
⁴Deparment of Medicine, University of Toronto, Toronto, ON, CAN
⁵Departments of Medicine, and Laboratory Medicine and Pathobiology, St. Michael’s Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, ON, Canada

5042

Association between Food Insecurity, Financial Toxicity, and Healthcare Utilization in Patients with Lymphoma

Kishan A Bhatt, MPA¹^*, David M. DeStephano, MPH²^*, Rhea K Khurana, MPH³^*, Claire Sathe, MD, JD⁴^*, Seda S. Tolu, MD⁵, Hua-Jay J. Cherng, MD⁶^*, Jennifer E. Amengual, MD⁷, Barbara Pro, MD⁸, Dawn L Hershman, MD, MS, FASCO⁹^*, Justine M. Kahn, MD, MSc¹⁰ and Melissa P Beauchemin, PhD, RN, CPNP-PC¹¹^*

¹Columbia University Vagelos College of Physicians and Surgeons, New York, NY
²Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
³Columbia University School of Nursing, New York, NY
⁴New York Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY
⁵Division of Hematology & Oncology, Columbia University Irving Medical Center, New York City, NY
⁶Columbia University Irving Medical Center, New York, NY
⁷Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
⁸Lymphoma Program, Division of Hematology & Oncology, Columbia University, New York, NY
⁹Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
¹⁰Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY
¹¹Division of Scholarship & Research, Columbia University School of Nursing, New York, NY

2340

Health Disparities in Lived Experiences of Patients with Cutaneous T-Cell Lymphoma: An All of Us Database Analysis

Sara Suhl, BS^1,2^*, Alexander Kaminsky, BS²^*, Abigail Marx, BS, MPH²^*, Sophia Luyten, BS²^*, Ikenna David Nebo, BA²^*, Barbara Pro, MD³ and Larisa J Geskin, MD⁴^*

¹Columbia University Vagelos College of Physicians and Surgeons, New York City, NY
²Columbia University Vagelos College of Physicians and Surgeons, New York, NY
³Lymphoma Program, Division of Hematology & Oncology, Columbia University, New York, NY
⁴Department of Dermatology, Columbia University, New York, NY

5073

Assessing the Contribution of Duffy Null Phenotype to Disparities in Eligibility Criteria for Clinical Trials for Newly-Diagnosed Colorectal Cancer

Lauren E. Merz, MD, MSc^1,2, Yating Wang, MS³^*, Elad Sharon, MD, MPH⁴^*, Thomas P Walsh⁵^*, Gregory Abel, MD, MPH⁵ and Andrew Hantel, MD⁶

¹Division of Hematology/Oncology, Mass General Brigham, Boston, MA
²Department of Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA
³Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁴Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁶HMS Center for Bioethics, Dana-Farber Cancer Institute, Boston, MA

3661

Associations of Long-Term Financial Hardship with Autologous Transplant and Overall Survival in Patients with Multiple Myeloma

Christopher T. Su, MD, MPH^1,2, Rahul Banerjee, MD, FACP^1,2, Li Li, MA MPA¹^*, Catherine Fedorenko, MMSc¹^*, Andrew J. Cowan, MD^1,2, Scott D. Ramsey, MD PhD^1,2^* and Veena Shankaran, MD MS^1,2^*

¹Fred Hutchinson Cancer Center, Seattle, WA
²University of Washington, Seattle, WA

2261

Routine Screening of African American Males in Hematology Oncology Clinic for G6PD Deficiency: A Prospective Comparative Study of a Pharmacogenomic Panel Versus Standard Enzyme Assay

Srishti Sareen, MD^1,2, Jaya Adabala^1,2^*, Katie Stoops^1,2^*, Jacob Marler¹^*, Lindsey Lands, MD^1,2^* and Alva Weir, MD^1,2^*

¹VA Medical Center, Memphis, TN
²UTHSC, Memphis, TN

See more of: ASH Poster Walks

<< Previous Poster Walk Application | Next Poster Walk Application >>